The Effects of an Oral Probiotic Intervention With or Without a Novel ADP-1 Toothpaste
Randomized Double-blind, Placebo-controlled Trial on the Effects of an Oral Probiotic Intervention With or Without a Novel ADP-1 Toothpaste
1 other identifier
interventional
105
1 country
1
Brief Summary
- Randomized double-blind, placebo-controlled trial on the effects of an oral probiotic intervention with or without a novel ADP-1 toothpaste Objective
- Determine the safety and effectiveness of oral probiotic intervention with or without a novel toothpaste and compare with placebo
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 26, 2021
CompletedFirst Submitted
Initial submission to the registry
February 8, 2022
CompletedFirst Posted
Study publicly available on registry
April 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 16, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 16, 2022
CompletedApril 21, 2023
April 1, 2023
1.1 years
February 8, 2022
April 19, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Gingival Index
• Gingival Index measures gingival condition of the marginal and interproximal tissues (mesial, lingual, distal, facial) separately on the basis of 0 to 3 with 0=Normal gingiva; 1= Mild inflammation - slight change in color and slight edema but no bleeding on probing; 2= Moderate inflammation - redness, edema and glazing, bleeding on probing; 3= Severe inflammation - marked redness and edema, ulceration with tendency to spontaneous bleeding.
8 weeks
Plaque Index
• Plaque index is used as a method of recording the presence of plaque on individual tooth surfaces. These surfaces are mesial, distal, buccal and lingual.
8 weeks
Secondary Outcomes (4)
Halitosis
8 weeks
Intraoral Imaging
8 weeks
SAQ
8 weeks
Microbial Community Analysis
8 weeks
Study Arms (3)
: Oral probiotic lozenges + placebo toothpaste (toothpaste without ADP-1)
OTHER1 active oral probiotic with placebo toothpaste
Oral probiotic lozenges + toothpaste with ADP-1
ACTIVE COMPARATOROral probiotic and ADP1 toothpaste
Placebo lozenges (lozenges without oral probiotics) + placebo toothpaste (toothpaste without ADP-1)
PLACEBO COMPARATORPlacebo without oral probiotics or ADP1 toothpaste
Interventions
an oral probiotic intervention with or without a novel ADP1 toothpaste
placebo without Oral probiotic or toothpaste
Eligibility Criteria
You may qualify if:
- Ages 18 to 65 years old
- Fluent in English
- Have mild to moderate gingivitis (i.e., probing depth between 3mm and 5mm)
- Bleeding on probing on 30%+ areas
- Able to perform oral hygiene adequately after formal instructions
- Able to understand and comply with study procedure
- Able to provide written informed consent
- Able to come to Roseman Dental Clinics in South Jordan for a 90-minute pre-screening to determine eligibility
- Able to complete five (90-minute) clinic visits in 2-week intervals
You may not qualify if:
- Probing depths less than 3mm
- Breastfeeding, pregnant or trying to become pregnant
- Currently taking or have taken any of the following within 30 days of enrollment:
- Oral probiotics
- Antibiotic medications
- Antifungal medications (e.g., nystatin, clotrimazole, ketoconazole, griseofulvin)
- Antiseptic medications
- Immunosuppressant and/or chemotherapeutic medications
- Medications that could affect gum response measurement (e.g., calcium channel blockers, cyclosporin, anti-seizures like phenytoin and related drugs, anti-inflammatory agents)
- Frequent alcohol consumption (\> 2 drinks per day, or \> 8 per week for women, or \> 15 per week for men)
- Use of marijuana (which can cause dry mouth or other conditions) or recreational drugs
- Use of tobacco products including chewing tobacco and all types of cigarettes (e-cigarettes)
- Known allergy to any product ingredient (ingredient list provided by USANA)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- USANA Health Scienceslead
- Roseman University of Health Sciencescollaborator
Study Sites (1)
Roseman University of Health Sciences College of Dental Medicine
South Jordan, Utah, 84095, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 8, 2022
First Posted
April 15, 2022
Study Start
October 26, 2021
Primary Completion
December 16, 2022
Study Completion
December 16, 2022
Last Updated
April 21, 2023
Record last verified: 2023-04